🇺🇸 FDA

Intelligence Platform

Patents

Browse 13 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12116416

Targeting intracellular target-binding determinants with intracellular antibodies

United States Government as represented by the Department of Veterans Affairs · Granted Tue Oct 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11224577

Treating infection by a platelet-targeting microbe using nanoparticles

The Regents of the University of California · Granted Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10683363

Targeting intracellular target-binding determinants with intracellular antibodies

The United States of America as represented by the Department of Veteran Affairs · Granted Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10507284

Daily periodic target-zone modulation in the model predictive control problem for artifici

The Regents of the University of California · Granted Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10500167

Droplet-embedded microfibers, and methods and devices for preparing and using same

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10450358

Platelet-derived growth factor B mutant, preparation method therefor and use thereof

Institute of Biotechnology, Academy of Military Medical Sciences, China · Granted Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9751932

Anti-big-endothelin-1 (big-ET-1) antibodies and uses thereof

REGENERON PHARMACEUTICALS, INC. · Granted Tue Sep 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 31 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9663790

Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase exp

The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9427469

Soluble physiological chitosan formulations combined with platelet-rich plasma (PRP) for t

ORTHO REGENERATIVE TECHNOLOGIES INC. · Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8808735

Fast wet-massing method for the preparation of calcium-containing compositions

TAKEDA NYCOMED AS · Granted Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8349568

Method of diagnosing poor survival prognosis colon cancer using let-7g

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Jan 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6660488

Antibodies for the alpha platelet-derived growth factor receptor

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Dec 09 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6228600

Immunoassays for the alpha platelet-derived growth factor receptor

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 08 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired